• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Articles published by Organon

    REPEAT/Organon & Samsung Bioepis Announce US Launch of HUMIRA Biosimilar HADLIMA™ (adalimumab-bwwd) in Multiple Presentations Consistent with Originator
    From Organon
    Via Business Wire
    Tickers OGN
    Organon Reports Results for the Fourth Quarter and Full Year Ended December 31, 2022
    From Organon
    Via Business Wire
    Tickers OGN
    Organon and ObsEva Enter Global License Agreement to Develop and Commercialize Ebopiprant (OBE022), an Investigational Agent Being Evaluated as a First-in-Class Treatment for Preterm Labor
    From Organon
    Via Business Wire
    Tickers OBSV OGN
    ADDING MULTIMEDIA Organon Launches as New Global Women’s Health Company
    From Organon
    Via Business Wire
    Tickers OGN
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.